Pfizer
Vasu Vats has extensive experience in the pharmaceutical industry, currently serving as Vice President and Global Head of Marketing for Inflammation and Immunology at Pfizer since September 2006. Vasu has held several key positions at Pfizer, including Global Commercial Lead for Xeljanz and Etrasimod, as well as leadership roles in areas such as Eliquis, internal medicine strategy, and cardiovascular and metabolic diseases. Vasu's expertise also extends to marketing management and strategy enablement, with previous positions in market access and outcomes research. In addition, Vasu is a member of the Board of Advisors for MaMome and a Young Global Leader at the World Economic Forum. Vasu holds a Master of Public Health in International Community Health from New York University.
This person is not in the org chart
This person is not in any teams
Pfizer
604 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.